Exim Advice (Export Import Consultant)’s Post

In the period from January to April 2024, China's inositol exports amounted to over 4,000 tons, with an export value exceeding 30 million USD. Compared to the same period last year, the quantity increased while the value decreased, with export prices continuing to decline. The main importing countries were the United States, the Netherlands, India, Germany, and Thailand. #APIs #Medical #Rawmaterials #Pharma #Medicine #Pharmaceutical

Amid the complex challenges facing the global economy and a slight weakening in growth momentum, the global pharmaceutical market has seen a slowdown in growth. However, the vitality of research and innovation remains strong, indicating profound changes within the industry and sustained development potential. Meanwhile, the ongoing expansion of the generic drug market provides growth opportunities for China's pharmaceutical import and export trade. Various major global markets have adopted different policy measures to reduce prices and control costs, improving drug accessibility. At the same time, the continuous updating and improvement of regulatory policies have placed higher demands on the quality and market adaptability of imported drugs. China's pharmaceutical import and export data reveals new trends in industry development: In the first half of 2024, the total import and export value of pharmaceuticals reached $52.96 billion, representing a 2.5% decline compared to the same period last year. However, this decrease is noticeably smaller than in previous periods, indicating that the market is gradually stabilizing. Of this total, exports amounted to $26.97 billion, a year-on-year increase of 2.0%, while imports totaled $25.99 billion, a year-on-year decrease of 6.8%. #APIs #Rawmaterials #Pharma #Medicine #Pharmaceutical

The #industry #appeals for official involvement as #geopolitical concerns push down #Indian pharmaceutical exports to #Africa. #Pharmaceutical #exports in #Africa have taken a significant hit due to the #depreciation of #local #currencies, driven by #geopolitical tensions, particularly in the #RedSea region. According to Sandeep Modi, joint secretary, #Federation of Pharmaceutical and Allied Products Merchant Exporters (#FPME), the impact on exports has been substantial, with a reported decline of up to #50%. Modi emphasized that the adverse effects are not limited to sales figures but also extend to #cash #flow within the #industry. #Shantipharmaceuticals

Exports are expected to cross $31 billion in the year ending March 31, compared with exports of nearly $28 billion in fiscal 2024, according to Pharmaceuticals Export Promotion Council of India (Pharmexcil). #india #pharmacy #pharmaceuticals #import #export #surge #growth #trade #internationaltrade #news #shipping #tradeagreement

The exports of pharmaceutical in Pakistan witnessed an increase of 31.11 per cent during the first quarter of the current financial year 2024-25, as against the exports of the corresponding months of last year. The pharmaceutical exports from the country were recorded at US $105.936 million during July-September (2024-25) against the exports of US $80.796 million during July-September (2023-24), according to the latest figures released by the Pakistan Bureau of Statistics (PBS). Meanwhile, year-on-year basis, the pharmaceutical exports witnessed an increase of 61.55 percent during the month of September 2024 as compared to the same month of last year. The exports of pharmaceutical from the country during September 2024 were recorded at US $43.607 million against the exports of US $26.992 million in September 2023. #Pakistan #Pharmaceutical #exports #increase #quarter #Trump #election #karachi #airport #surge #pollution #loan #team #247newsupdate

🌟 Updates from the Portuguese Pharmaceutical Sector 🌟 After a year of remarkable growth in 2022, we are facing challenges and looking for new opportunities to boost our sector. The sector's turnover showed more moderate growth compared to the previous year. Exports remained strong, albeit with more modest growth, maintaining the United States as an important destination market. Growing imports and a deficit in the trade balance highlight the need for innovation and competitiveness. Do you want to stay on top of trends and prospects in the pharmaceutical sector in Portugal? Keep following our page for more updates! #Neutroplast #PharmaceuticalSector 

🔥India replaces Germany as Russia’s top medicine supplier, supplies 294 million packages of pharmaceuticals in 2023. 🎯India Emerges as Top Supplier: According to data from RNC Pharma, a market research firm, India has overtaken Western nations as the leading supplier of medicines to Russia. 🎯Export Surge: Indian pharmaceutical companies increased their exports to Russia by 3% in 2023, reaching nearly 294 million boxes of medicine. 🎯Shifting Dynamics: This change is attributed partly to Western companies reducing non-essential operations and investments in Russia due to the Ukraine conflict. Germany, the previous leader, saw a supply drop of almost 20% in 2023. #India #Russia #MedicineSupply #ShiftingLandscape #GlobalPharma #Trade #Geopolitics #Healthcare #IndiaRising #PharmaPowerhouse #LifelinetoRussia #MakeInIndia #AffordableHealthcare #GlobalLeader

India's pharma exports to US surge 15% in 11 months of FY24 The pace of exports has more than doubled from the 6.18% growth in the same period of FY23, according to estimates by Pharmaceutical Export Promotion Council (Pharmexcil). #IndiaPharma | #FY24 | #PharmaceuticalExportPromotion | #PaceofExports | #Healthnews Read more:

Indian Pharm Exports grows at 10.2%. In May 2024, India's pharmaceutical exports showed significant growth. The export value for drugs and pharmaceuticals increased by 7.36%, rising from USD 2.26 billion in April 2023 to USD 2.43 billion in April 2024. For the fiscal year 2023-24, the total pharmaceutical exports were projected to reach USD 28 billion, marking an incremental growth of 10.2% compared to the previous fiscal year. This growth was driven by increased demand in the United States and Europe due to critical drug shortages in this region. Growth highlights India's role as a key supplier of pharmaceuticals globally, despite facing challenges such as stringent regulatory requirements, supply chain disruptions, and quality control issues. The sector's expansion reflects both resilience and the capacity to address global health needs effectively.